Basket | Login

 
 
 
 

LOVESTONE Simon (United Kingdom)

Professor Sir Simon Lovestone BM, PhD is Vice President, Disease Area Leader, Neurodegeneration; since September 2018, proud to be part of an outstanding global team developing therapeutics for diseases causing neurodegeneration from discovery through to clinic. Prior to his current role, Simon Lovestone was Professor of Translational Neuroscience at Oxford University where he initiated and was joint lead academic scientist with Chas Bountra of the Alzheimer’s Research UK Drug Development Institute. Before this he spent close to 25 years at King’s College London and the Maudsley Hospital including leading the NIHR Biomedical Research Centre, the UK’s largest centre for experimental medicine in mental health and dementia and being Director of R&D for King’s Health Partners, an Academic Health Sciences Centre working to integrate clinical sciences across three NHS Trusts and the University. He established and led the NIHR Translational Research Collaboration in Dementia (a network of six Biomedical Research Units and Centres in England focused on dementia), was co-coordinator of the European Medical Information Framework (IMI-EMIF) and was instrumental in establishing the European Prevention of Alzheimer’s Disease (IMI-EPAD) led by Serge Van der Geyten (Janssen) and Craig Ritchie (Edinburgh). His own research interests are in the mechanisms of Alzheimer’s Disease and in the search for biomarkers and building on these, in drug discovery and experimental medicine. Underpinning all these studies is the use of informatics – clinical informatics, bioinformatics and the challenges of extracting value from very large variable datasets. He is also a practicing Old Age Psychiatrist specialising in dementia detection, diagnosis and management. He studied Microbiology at Sheffield University, Medicine at Southampton University and was awarded an MPhil and then a PhD from the University of London for research on mental health in new fathers and the role of GSK3 in phosphorylation of tau respectively. He was knighted for services to Neuroscience research in 2017.

 

 
 

Last Updated: Wednesday 08 July 2020

 

Options